Citation 88106

TEWTRAKUL,S: NAKAMURA,N: HATORI,M: FUJIWARA,T: SUPAVITA,T:. (2002). FLAVANONE AND FLAVONOL GLYCOSIDES FROM THE LEAVES OF THEVETIA PERUVIANA AND THEIR HIV-1 REVERSE TRANSCRIPTASE AND HIV-1 INTEGRASE INHIBITORY ACTIVITIES.. 50(5)

Citation Details

Title	FLAVANONE AND FLAVONOL GLYCOSIDES FROM THE LEAVES OF THEVETIA PERUVIANA AND THEIR HIV-1 REVERSE TRANSCRIPTASE AND HIV-1 INTEGRASE INHIBITORY ACTIVITIES.
Authors	TEWTRAKUL,S: NAKAMURA,N: HATORI,M: FUJIWARA,T: SUPAVITA,T:
Year	2002
Volume	50
Issue	5

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (2)

Thevetia peruviana (APOCYNACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FOR	None	None
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN VITRO	None	ACTIVE
3	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF EXTRACT - IN VITRO	None	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
2	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	INACTIVE
3	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL	ACTIVE
4	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	THEVIRIDOSIDE	None
5	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THEVIRIDOSIDE	INACTIVE
6	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THEVIRIDOSIDE	INACTIVE
7	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THEVIRIDOSIDE	INACTIVE
8	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	THEVESIDE	None
9	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THEVESIDE	INACTIVE
10	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THEVESIDE	INACTIVE
11	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	THEVESIDE	INACTIVE
12	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	PERUVIANOSIDE I	None
13	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERUVIANOSIDE I	INACTIVE
14	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERUVIANOSIDE I	INACTIVE
15	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERUVIANOSIDE I	INACTIVE
16	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FOR	PERUVIANOSIDE II	None
17	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERUVIANOSIDE II	INACTIVE
18	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERUVIANOSIDE II	INACTIVE
19	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERUVIANOSIDE II	INACTIVE
20	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	None
21	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
22	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
23	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
24	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	None
25	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
26	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
27	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
28	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN-3-O-[(6-O-SINAPOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	None
29	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[(6-O-SINAPOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
30	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[(6-O-SINAPOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
31	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[(6-O-SINAPOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
32	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAEMPFEROL-3-O-[(6-O-SINAPOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALATOPYRANOSIDE]	None
33	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[(6-O-SINAPOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALATOPYRANOSIDE]	INACTIVE
34	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[(6-O-SINAPOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALATOPYRANOSIDE]	INACTIVE
35	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[(6-O-SINAPOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALATOPYRANOSIDE]	ACTIVE
36	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN-3-O-[(6-O-FERULOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	None
37	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[(6-O-FERULOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
38	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[(6-O-FERULOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
39	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[(6-O-FERULOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
40	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAEMPFEROL-3-O-[(6-O-FERUCOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	None
41	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[(6-O-FERUCOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
42	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[(6-O-FERUCOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
43	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[(6-O-FERUCOYL)-BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
44	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE]	None
45	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE]	ACTIVE
46	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE]	INACTIVE
47	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE]	ACTIVE
48	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE]	None
49	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE]	ACTIVE
50	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE]	INACTIVE
51	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-BETA-D-GLUCOPYRANOSIDE]	INACTIVE
52	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PERUVIANOSIDE III	None
53	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERUVIANOSIDE III	INACTIVE
54	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERUVIANOSIDE III	INACTIVE
55	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PERUVIANOSIDE III	INACTIVE
56	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GALACTOPYRANOSIDE]	None
57	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
58	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GALACTOPYRANOSIDE]	INACTIVE
59	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KAEMPFEROL-3-O-[BETA-D-GLUCOPYRANOSYL(1-2)-[ALPHA-L-RHAMNOPYRANOSYL(1-6)]-BETA-D-GALACTOPYRANOSIDE]	ACTIVE
60	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	QUERCETIN	None
61	RNA DEPENDENT DNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
62	DNA DEPENDENT RNA POLYMERASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
63	HIV-1 INTEGRASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE